Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/23/25 15:16 | 5/22/25 | GILD | Health | BioPrd | Biological Products, (No Diag | Mercier Johanna | CA | O | Chief Co | 3 | M.d | 4,677 | 76.56 | 0 | 61 | 97 | 124 | D | ||||||||||||||
5/23/25 15:16 | 5/22/25 | GILD | Health | BioPrd | Biological Products, (No Diag | Mercier Johanna | CA | O | Chief Co | 3 | S.d | -4,677 | 76.56 | 0 | -61 | 124 | D | |||||||||||||||
5/16/25 16:34 | 5/15/25 | GILD | Health | BioPrd | Biological Products, (No Diag | Dickinson Andrew D | CA | O | CFO | 5 | S.d | -4,056 | 79.03 | 0 | -51 | 173 | D | |||||||||||||||
4/28/25 13:24 | 4/25/25 | GILD | Health | BioPrd | Biological Products, (No Diag | Telman Deborah H | CA | O | EVP,Corp | 2 | M.d | 0 | 0.00 | 0 | 4 | 12 | 37 | D | ||||||||||||||
3/12/25 19:12 | 3/10/25 | GILD | Health | BioPrd | Biological Products, (No Diag | O'Day Daniel Patrick | CA | DO | CB,CEO | 1 | M.d | 0 | 0.00 | 0 | 24 | 4 | 630 | D | ||||||||||||||
3/12/25 18:10 | 3/10/25 | GILD | Health | BioPrd | Biological Products, (No Diag | Patterson Sandra | CA | O | SVP,Cont | 1 | M.d | 0 | 0.00 | 0 | 2 | 5 | 39 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |